-
Tata Motors
647.20 542.55(%) -
Axis Bank
1,060.20 934.00(%) -
Vimta Labs
677.30 235.00(%) -
GE Vernova T&D
2,871.15 2,871.15(%) -
Netweb Technol.
2,299.15 3,060.00(%) -
Suzlon Energy
66.80 86.04(%) -
Kaynes Tech
6,483.00 7,824.95(%) -
M & M
3,117.25 2,360.45(%) -
PNB Housing
803.30 746.10(%) -
Waaree Energies
3,163.55 3,740.75(%) -
HDFC Bank
2,010.00 1,593.20(%) -
Jayaswal Neco
48.32 26.06(%) -
Skipper
548.00 665.00(%) -
Shree Refrigerat
177.70 177.70(%) -
Timex Group
244.75 289.90(%) -
Hind. Unilever
2,728.10 3,034.50(%) -
TCS
3,000.00 3,000.00(%) -
Ceinsys Tech
1,750.85 538.20(%) -
Swiggy
386.25 297.00(%) -
KIOCL
374.20 461.35(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Wanbury Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- PPI
- BSE Code : 2393.0
- ISIN : INE107F01022
-
Today’s Low
260.00 -
Today’s High
272.00

-
Open
266.00 -
Perv Close
268.90 -
52W Low
154.01 -
52W High
329.70
Key Indicators
-
P/E(TTM)
29.04
-
Mar.Cap (₹Cr.)
882.58
-
Div & Yield %
0.00
-
Book Value(₹)
18.06
-
Debt-Equity Ratio
-0.17
-
AGM Date
01-Aug-2025
-
EPS
9.29
-
P/E Ratio
29.04
Financials Ratios
-
Debt-Equity Ratio
0.00
-
Mar.Cap (₹Cr.)
882.58
-
RONW (%)
49.77
-
ROCE (%)
33.46
Score Board
-
Equity (₹ in Cr.)
32.88
-
BV (₹)
18.10
-
Sales( ₹ in Cr.)
599.51
-
NP (in Cr.)
30.53
-
NP Var(%)
2.0
-
Div%
0.0
-
CPS (₹)
13.30
-
EPS (₹)
9.30
-
Traded Value (₹ in Lakhs)
886.86
-
52 Week High
329.70
-
52 Week Low
154.01
-
Price BSE
270.0
-
Price NSE
268.00
-
Market Capital( in Cr.)
886.86
-
P/C Ratio
20.20
-
P/E Ratio
29.10
-
Price Vs.BV
9.30
-
29-Jul-2025( 09:47)
Corporate News - Wanbu... - Wanbury will hold a meeting of...
-
20-May-2025( 10:09)
Hot Pursuit - Wanbu... - Earlier this month, on 12 May...
-
16-May-2025( 08:08)
Results - Announcements - Wanbu... - Net profit of Wanbury declined...
-
16-May-2025( 08:07)
Results - Announcements - Wanbu... - Net profit of Wanbury rose 150...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 575.65 | 499.65 | 511.19 | 392.52 | 367.45 | 391.37 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 575.65 | 499.65 | 511.19 | 392.52 | 367.45 | 391.37 |
Other Income | 2.99 | 0.91 | 77.88 | 2.40 | 83.78 | 9.33 |
Stock Adjustments | 3.89 | -29.13 | 24.79 | 7.20 | -5.99 | 5.06 |
Total Income | 582.53 | 471.43 | 613.86 | 402.12 | 445.24 | 405.76 |
EXPENDITURE : | ||||||
Raw Materials | 306.52 | 274.31 | 325.07 | 228.53 | 169.75 | 201.26 |
Power and Fuel Cost | 24.58 | 20.59 | 18.41 | 17.13 | 15.38 | 14.46 |
Employee Cost | 86.92 | 81.00 | 74.81 | 64.15 | 67.48 | 75.89 |
Other Manufacturing Expenses | 13.32 | 11.43 | 12.66 | 9.98 | 13.77 | 7.98 |
Selling and Administration Expenses | 58.51 | 45.16 | 55.34 | 45.49 | 55.36 | 63.70 |
Miscellaneous Expenses | 19.69 | 15.45 | 14.36 | 16.42 | 16.29 | 17.59 |
Employee Benefit Expenses | 86.92 | 81.00 | 74.81 | 64.15 | 67.48 | 75.89 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 509.54 | 447.94 | 500.65 | 381.70 | 338.02 | 380.89 |
Operating Profit | 72.99 | 23.49 | 113.19 | 20.42 | 107.23 | 24.86 |
Interest | 29.18 | 21.39 | 20.61 | 23.07 | 32.87 | 39.88 |
Gross Profit | 43.81 | 2.10 | 92.58 | -2.65 | 74.36 | -15.02 |
Depreciation | 13.03 | 12.38 | 11.45 | 9.75 | 9.68 | 9.97 |
Profit Before Tax | 30.78 | -10.28 | 81.13 | -12.40 | 64.68 | -24.99 |
Current Tax | 0.00 | 0.00 | 0.00 | 2.27 | 0.00 | 0.00 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.38 | 0.11 | -0.35 | -2.07 | 0.21 | -0.14 |
Reported Net Profit | 30.40 | -10.40 | 81.47 | -12.61 | 64.46 | -24.85 |
Extraordinary Items | 0.49 | -0.31 | 76.06 | 1.21 | 82.62 | 0.12 |
Adjusted Net Profit | 29.91 | -10.09 | 5.41 | -13.82 | -18.16 | -24.97 |
Adjustment below Net Profit | -0.59 | 0.26 | 0.80 | -0.44 | -0.46 | 0.31 |
P & L Balance brought forward | -168.14 | -158.01 | -240.28 | -227.23 | -291.23 | -266.69 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance carried down | -138.34 | -168.14 | -158.01 | -240.28 | -227.23 | -291.23 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Per Share-Unit Curr | 9.28 | -3.18 | 24.94 | -5.04 | 25.79 | -10.48 |
Earnings Per Share(Adj)-Unit Curr | 9.28 | -3.18 | 24.94 | -5.04 | 25.79 | -10.48 |
Book Value | 6.70 | -2.26 | 0.57 | -52.23 | -47.14 | -77.40 |
Book Value(Adj)-Unit Curr | 6.70 | -2.26 | 0.57 | -52.23 | -47.14 | -77.40 |